Biotron

BIT.AX

Tags: AU Healthcare Biotechnology

Biotron Limited Price (BIT.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

902,170,065

(9.9079)%

Market Cap of Biotron (BIT.AX)

Market cap:

As of , BIT.AX has a market cap of . This makes BIT.AX the 1225th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.003-0.11
Market Cap 6.32M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.
IPO Date: January, 23, 2001
Country: AU
Currency: AUD
Headquaters: Sydney, NSW
Employees: 4

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: